NEW YORK, Oct 20 – Just two days after its birth as a spin off from Theratechnologies, microbial genomics company Ecopia BioSciences said Friday it had signed a microbial sequencing deal with Kosan BioSciences.

Under the agreement, Ecopia will apply its genomics platform in order to discover the genes of a particular microorganism that direct the synthesis of an undisclosed small molecule, which is of interest to Kosan.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.

Retraction Watch's Ivan Oransky and Adam Marcus report that Harvard Medical School and Brigham and Women's Hospital have recommended that more than 30 papers from a former researcher be retracted.

Thomas Steitz, who won the 2009 chemistry Nobel Prize for his ribosome work, has died, the Washington Post reports.

In PLOS this week: mechanisms for genes implicated in coronary artery disease, rumen microbes and host genetics influence cow methane production, and more.